Adding inflammatory markers to T2D clustering reveals a distinct inflammation-dominant insulin resistance phenotype in men ...
People with type 2 diabetes who nap longer than 30 minutes every day, regardless of their sleep patterns at night, increase their risk of developing metabolic dysfunction-associated steatotic liver ...
The U.S. FDA has expanded the approval of teplizumab (Tzield) to include children aged 8 years and older who have been ...
Everyday Health on MSN
Do long naps raise liver disease risk if you have diabetes?
A new study shows a link between long naps and a form of chronic liver disease known as MASLD, but experts say the connection ...
The new drug would add another oral GLP-1 with no fasting or fluid intake restrictions to clinicians’ toolboxes, improving options for targeted treatment.
A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes ...
Recently, mortality from breast cancer has decreased due to effective endocrine therapies;. However, many recovered patients have reported the development of type 2 diabetes mellitus (T2DM) following ...
The FDA expanded the approval of teplizumab (Tzield) to include pediatric patients 8 years and older who have recently been diagnosed with stage 3 type 1 diabetes, the clinical stage where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results